Coronary Artery Disease: Warning Signs, Risk Factors, and Medical Management
Coronary Artery Disease (CAD) is the leading cause of mortality worldwide, resulting from atherosclerotic plaque accumulation within the epicardial coronary vessels. Explore modern diagnostic algorithms (Coronary Artery Calcium scoring, CT Coronary Angiography), medical management (high-intensity statins, beta-blockers, ACE inhibitors), and revascularization indications.
Hands-free audio narration
This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.
Quick Summary & Key Findings
Coronary Artery Disease is diagnosed via ECG, cardiac biomarkers (Troponin), Coronary CT Angiography, or Invasive Angiography. Management combines lifestyle optimization with high-intensity statin therapy, antiplatelet agents (Aspirin), blood pressure control, and revascularization (PCI with drug-eluting stents or CABG) when hemodynamically significant stenosis exists.
In cardiovascular medicine, Coronary Artery Disease (CAD) remains the single greatest contributor to sudden cardiac death and heart failure. Atherosclerosis is not simply a plumbing issue of 'grease clogging pipes'—it is a chronic, low-grade inflammatory disease of the arterial intimal layer.
Apolipoprotein B (ApoB) containing lipoproteins penetrate endothelial micro-fissures, become oxidized, and trigger macrophage infiltration, forming foam cells, fatty streaks, and ultimately fibroatheromatous plaques with necrotic lipid cores.
Understanding the distinction between stable angina (exertional flow-limiting stenosis) and acute coronary syndromes (plaque rupture with acute occlusive thrombosis) is critical for timely medical intervention and life-saving care.
Pathophysiology: Plaque Rupture vs. Stable Ischemia
Diagnostic Modalities for Coronary Artery Disease
| Diagnostic Test | Clinical Purpose | Sensitivity / Specificity | Ideal Patient Profile |
|---|---|---|---|
| Coronary Artery Calcium (CAC) Scan | Non-contrast CT measuring calcified plaque volume (Agatston Score). | High Sensitivity (~98%), Moderate Specificity | Asymptomatic intermediate-risk adults determining statin initiation. |
| Coronary CT Angiography (CCTA) | Contrast CT imaging anatomy of coronary lumen and plaque morphology. | Sensitivity 95–99%, Specificity 88–92% | Symptomatic low-to-intermediate risk outpatients with chest pain. |
| Stress Echocardiogram / Nuclear SPECT | Evaluates myocardial perfusion and inducible wall motion abnormalities under exertion. | Sensitivity 80–88%, Specificity 75–85% | Patients with exertional chest tightness or suspected exercise-induced ischemia. |
| Invasive Coronary Angiography (Cath) | Gold standard catheterization for direct visualization and immediate PCI/stenting. | Definitive Diagnostic & Interventional Gold Standard | Acute coronary syndromes, STEMI/NSTEMI, or refractory severe angina. |
Classic vs. Atypical Symptoms of Myocardial Ischemia
Frequently Asked Questions
Dr. Ashok Seth, MBBS, MD, FRCP, FACC
Chairman, Fortis Escorts Heart Institute & Lead Interventional Cardiologist • MBBS, MD, FRCP (London, Edin, Glasg), FACCDr. Ashok Seth is the Chairman of Fortis Escorts Heart Institute, Okhla, New Delhi, and one of the world's foremost interventional cardiologists. He has pioneered cutting-edge techniques in coronary angioplasty, TAVR/TAVI, and directional atherectomy with over 35 years of clinical practice.
References & Clinical Resources
- Virani SS, Newby LK, Arnold SV, et al.. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023). [Access Resource Link] — Circulation. 148(9):e9-e119
- Libby P, Theroux P. Coronary Atherosclerosis: Pathophysiology and Clinical Implications (2005). [Access Resource Link] — Circulation. 111(25):3481-3488
- Hoffmann U, Truong QA, Schoenfeld DA, et al.. Coronary Computed Tomography Angiography for the Evaluation of Patients with Acute Chest Pain (2012). [Access Resource Link] — New England Journal of Medicine. 367(4):299-308
Related Healthcare Guides
Reader Reviews & Clinical Q&A
Real experiences, reader questions, and verified physician guidance.
This guide broke down the exact diagnostic thresholds and medication pathways so clearly. My cardiologist recently discussed adjusting my regimen, and reading this helped me prepare specific questions for my follow-up visit.
Thank you for sharing, Marcus. Preparing targeted questions beforehand makes clinical consultations far more productive. Always discuss any dosage or timing adjustments directly with your attending physician.
The structured comparison tables and ACC/AHA clinical trial references are outstanding. I frequently print sections of this guide to explain lifestyle modifications to patients in our outpatient clinic.
We are honored to support your clinical practice, Patricia. Translating complex cardiovascular guidelines into patient-friendly education is the core mission of our editorial board.